of children with cancer resistant to conventional treatment die
of delay until the same new medicine already approved for adults gets approved for children
long-term survivors of childhood cancer live in Europe today. 2/3 of them experience long-term health related problems
To improve access for adolescents to new anti-cancer drugs and to make the drug development process more efficient
14th Paediatric Strategy Forum on novel ways to target and enhance
ASCPT
De Rojas, T. et al.
November 2023